Kayhan Ertürk

875 total citations
81 papers, 577 citations indexed

About

Kayhan Ertürk is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Kayhan Ertürk has authored 81 papers receiving a total of 577 indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Oncology, 26 papers in Molecular Biology and 19 papers in Epidemiology. Recurrent topics in Kayhan Ertürk's work include Cutaneous Melanoma Detection and Management (39 papers), Melanoma and MAPK Pathways (15 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Kayhan Ertürk is often cited by papers focused on Cutaneous Melanoma Detection and Management (39 papers), Melanoma and MAPK Pathways (15 papers) and Cutaneous lymphoproliferative disorders research (9 papers). Kayhan Ertürk collaborates with scholars based in Türkiye, United States and France. Kayhan Ertürk's co-authors include Faruk Taş, Derya Duranyıldız, Elif Bilgin, Didem Taştekin, Faruk Taş, Murat Serilmez, Senem Karabulut, Özlem Harmankaya, Şule Karaman and Yıldız Okuturlar and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Biomedicine & Pharmacotherapy.

In The Last Decade

Kayhan Ertürk

76 papers receiving 569 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kayhan Ertürk Türkiye 15 329 211 136 84 73 81 577
Magda Lourda Sweden 12 269 0.8× 239 1.1× 280 2.1× 62 0.7× 44 0.6× 23 644
Jennifer McCormick Ireland 12 138 0.4× 232 1.1× 311 2.3× 101 1.2× 44 0.6× 12 732
Yaning Yang China 13 362 1.1× 210 1.0× 137 1.0× 112 1.3× 82 1.1× 45 911
Saeed Aslani Iran 11 181 0.6× 206 1.0× 325 2.4× 73 0.9× 63 0.9× 23 737
Michael Stecher United States 11 200 0.6× 247 1.2× 253 1.9× 37 0.4× 89 1.2× 28 643
Wojciech Naumnik Poland 18 223 0.7× 371 1.8× 104 0.8× 161 1.9× 73 1.0× 60 768
Rony Weitzen Israel 11 186 0.6× 103 0.5× 76 0.6× 31 0.4× 50 0.7× 33 427
Cláudio Galleano Zettler Brazil 13 197 0.6× 153 0.7× 62 0.5× 100 1.2× 161 2.2× 43 597
Seishi Harada Japan 13 235 0.7× 164 0.8× 333 2.4× 68 0.8× 47 0.6× 26 932
J. Mann United Kingdom 7 100 0.3× 213 1.0× 107 0.8× 66 0.8× 124 1.7× 10 571

Countries citing papers authored by Kayhan Ertürk

Since Specialization
Citations

This map shows the geographic impact of Kayhan Ertürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kayhan Ertürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kayhan Ertürk more than expected).

Fields of papers citing papers by Kayhan Ertürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kayhan Ertürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kayhan Ertürk. The network helps show where Kayhan Ertürk may publish in the future.

Co-authorship network of co-authors of Kayhan Ertürk

This figure shows the co-authorship network connecting the top 25 collaborators of Kayhan Ertürk. A scholar is included among the top collaborators of Kayhan Ertürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kayhan Ertürk. Kayhan Ertürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ertürk, Kayhan, et al.. (2024). Evaluation of ixabepilone efficacy and tolerability in metastatic breast cancer. Medicine. 103(47). e40649–e40649. 2 indexed citations
2.
3.
Taş, Faruk & Kayhan Ertürk. (2021). Limb melanomas: acral melanomas have worse survival. Journal of Dermatological Treatment. 33(3). 1630–1637. 4 indexed citations
4.
Özden, Müge Güler, Kayhan Ertürk, Savaş Yaylı, et al.. (2020). An extraordinary outbreak of scabies in Turkey. Journal of the European Academy of Dermatology and Venereology. 34(12). e818–e820. 15 indexed citations
5.
Taş, Faruk & Kayhan Ertürk. (2020). Trends in the characteristics of skin melanoma in accordance with time intervals. Journal of Cancer Research and Therapeutics. 17(4). 1119–1122. 1 indexed citations
6.
Taş, Faruk & Kayhan Ertürk. (2019). Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma. Annals of Plastic Surgery. 83(4). 455–458. 2 indexed citations
7.
Taş, Faruk & Kayhan Ertürk. (2019). Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma. International Journal of Clinical Oncology. 24(6). 721–726. 2 indexed citations
8.
Taş, Faruk & Kayhan Ertürk. (2019). Cheek Cutaneous Melanomas. Annals of Plastic Surgery. 82(4). 407–410. 4 indexed citations
9.
Taş, Faruk & Kayhan Ertürk. (2019). BRAF mutation status might contribute an effect on both disease-free and overall survival in stage III cutaneous melanomas treated with intermediate dose interferon-alpha. Cancer Chemotherapy and Pharmacology. 84(3). 521–526. 3 indexed citations
10.
Taş, Faruk & Kayhan Ertürk. (2018). Palpebral cutaneous melanomas: a review of 17 cases from a tertiary center. International Journal of Dermatology. 58(1). 75–79. 5 indexed citations
11.
Taş, Faruk, Senem Karabulut, Kayhan Ertürk, & Derya Duranyıldız. (2018). Clinical significance of serum leptin level in patients with gastric cancer. European Cytokine Network. 29(2). 52–58. 9 indexed citations
12.
Taş, Faruk & Kayhan Ertürk. (2018). Relapse patterns in patients with local and regional cutaneous melanoma. Clinical & Translational Oncology. 21(4). 412–419. 10 indexed citations
13.
Taş, Faruk & Kayhan Ertürk. (2017). Anemia in Cutaneous Malignant Melanoma: Low Blood Hemoglobin Level is Associated with Nodal Involvement, Metastatic Disease, and Worse Survival. Nutrition and Cancer. 70(2). 236–240. 7 indexed citations
14.
Taş, Faruk & Kayhan Ertürk. (2017). Plantar melanoma is associated with certain poor prognostic histopathological factors, but not correlated with nodal involvement, recurrence, and worse survival. Clinical & Translational Oncology. 20(5). 607–612. 7 indexed citations
15.
Karabulut, Senem, Mehmet Karabulut, Çiğdem Usul Afşar, et al.. (2016). PANKREAS ADENOKARSİNOMLU HASTALARDA SERUM TRANSFORME EDİCİ BÜYÜME FAKTÖR BETA 1 (TGF-Β1) DÜZEYLERİ. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 79(1). 9–9. 1 indexed citations
16.
Taş, Faruk & Kayhan Ertürk. (2016). Presence of histological regression as a prognostic factor in cutaneous melanoma patients. Melanoma Research. 26(5). 492–496. 22 indexed citations
17.
Taş, Faruk, Elif Bilgin, Didem Taştekin, Kayhan Ertürk, & Derya Duranyıldız. (2016). Clinical Significance of Serum Galectin-3 Levels in Gastric Cancer Patients. Journal of Gastrointestinal Cancer. 47(2). 182–186. 9 indexed citations
18.
Karanlık, Hasan, Neslihan Cabıoğlu, Kayhan Ertürk, et al.. (2015). Preoperative chemotherapy for T2 breast cancer is associated with improved surgical outcome. European Journal of Surgical Oncology. 41(9). 1226–1233. 18 indexed citations
19.
Harmankaya, Özlem, et al.. (2015). Comparison of risk factors for cardiovascular disease in hemodialysis and peritoneal dialysis patients. Clinics. 70(9). 601–605. 23 indexed citations
20.
Taştekin, Didem, et al.. (2014). The efficacy of Pistacia Terebinthus soap in the treatment of cetuximab-induced skin toxicity. Investigational New Drugs. 32(6). 1295–1300. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magda Lourda Breakdown of academic impact, for papers by Jennifer McCormick Breakdown of academic impact, for papers by Yaning Yang Breakdown of academic impact, for papers by Saeed Aslani Breakdown of academic impact, for papers by Michael Stecher Breakdown of academic impact, for papers by Wojciech Naumnik Breakdown of academic impact, for papers by Rony Weitzen Breakdown of academic impact, for papers by Cláudio Galleano Zettler Breakdown of academic impact, for papers by Seishi Harada Breakdown of academic impact, for papers by J. Mann
Rankless by CCL
2026